Weiss Multi-Strategy Advisers’s Aldeyra Therapeutics ALDX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43,723	Closed	-$292K	–	530
2023 Q3	$292K	Sell	43,723 -6,277	-13%	-$46.6K	0.01%	503
2023 Q2	$420K	Sell	50,000 -8,968	-15%	-$88.4K	0.01%	585
2023 Q1	$586K	Sell	58,968 -14,228	-19%	-$101K	0.01%	546
2022 Q4	$509K	Sell	73,196 -4,496	-6%	-$25.7K	0.01%	510
2022 Q3	$415K	Sell	77,692 -2,543	-3%	-$15.3K	0.01%	563
2022 Q2	$320K	Sell	80,235 -49,765	-38%	-$171K	0.01%	582
2022 Q1	$578K	Buy	130,000 +2,553	+2%	+$10.2K	0.01%	547
2021 Q4	$510K	Sell	127,447 -19,992	-14%	-$152K	0.01%	550
2021 Q3	$1.29M	Buy	147,439 +6,535	+5%	+$60K	0.03%	469
2021 Q2	$1.6M	Sell	140,904 -10,779	-7%	-$130K	0.04%	436
2021 Q1	$1.8M	Buy	151,683 +39,231	+35%	+$452K	0.04%	420
2020 Q4	$771K	Sell	112,452 -4,543	-4%	-$31.9K	0.01%	517
2020 Q3	$867K	Buy	116,995 +1,301	+1%	+$8.4K	0.02%	437
2020 Q2	$482K	Sell	115,694 -31,563	-21%	-$115K	0.01%	471
2020 Q1	$364K	Sell	147,257 -52,743	-26%	-$237K	0.01%	362
2019 Q4	$1.16M	Hold	200,000	–	–	0.02%	474
2019 Q3	$1.05M	Hold	200,000	–	–	0.02%	439
2019 Q2	$1.2M	Hold	200,000	–	–	0.03%	361
2019 Q1	$1.81M	Buy	200,000 +15,000	+8%	+$127K	0.05%	343
2018 Q4	$1.54M	Hold	185,000	–	–	0.06%	252
2018 Q3	$2.55M	Buy	185,000 +144,800	+360%	+$1.17M	0.07%	297
2018 Q2	$320K	Sell	40,200 -7,200	-15%	-$57.4K	0.01%	507
2018 Q1	$356K	Sell	47,400 -2,600	-5%	-$19.7K	0.01%	480
2017 Q4	$340K	Hold	50,000	–	–	0.01%	516
2017 Q3	$360K	Sell	50,000 -12,000	-19%	-$62.7K	0.01%	448
2017 Q2	$288K	Sell	62,000 -3,000	-5%	-$13.8K	0.01%	482
2017 Q1	$325K	Hold	65,000	–	–	0.01%	502
2016 Q4	$348K	Hold	65,000	–	–	0.02%	354
2016 Q3	$508K	Sell	65,000 -610	-0.9%	-$3.73K	0.03%	342
2016 Q2	$373K	Sell	65,610 -5,562	-8%	-$31.1K	0.03%	344
2016 Q1	$298K	Sell	71,172 -4,828	-6%	-$23.2K	0.01%	411
2015 Q4	$515K	Hold	76,000	–	–	0.04%	303
2015 Q3	$443K	Buy	76,000 +58,500	+334%	+$457K	0.02%	329
2015 Q2	$136K	Buy	+17,500	New	+$151K	0.01%	422

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ALDX Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Aldeyra Therapeutics (ALDX) in Q4 2023, closing a stake of 43,723 shares — an estimated $292K sold.

Weiss Multi-Strategy Advisers first reported a position in ALDX in Q2 2015 and held it in 34 quarters. The position peaked at $2.55M in Q3 2018. 105 funds tracked by Wall St. Rank hold ALDX as of Q4 2023.

Weiss Multi-Strategy Advisers reported no remaining Aldeyra Therapeutics position as of Q4 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 43,723 Aldeyra Therapeutics shares in Q4 2023, an estimated $292K.
Weiss Multi-Strategy Advisers first reported a position in Aldeyra Therapeutics in Q2 2015 and held it in 34 quarters.
Weiss Multi-Strategy Advisers's Aldeyra Therapeutics position peaked at $2.55M in Q3 2018.
105 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.